We're building the MCT - 1 so the people who need continuous mast cell monitoring most are never priced out of it. Here's how we partner with insurance, public programs, and healthcare providers to make it covered and accessible.
Working toward in-network coverage as a recognized medical device.
Pursuing public-program pathways for seniors and low-income patients.
Prescribed, fitted, and monitored through your existing care team.
Sliding-scale pricing and aid so no one is turned away.
MastCell Tracker is a fully non-profit organization. We don't answer to shareholders — we answer to patients. Continuous biosensing is only meaningful if the people living with mast cell activation syndrome (MCAS), allergic disease, and chronic inflammation can actually get it in their hands. That belief shapes every coverage and access decision we make.
Any surplus we generate is reinvested straight back into mast cell research, patient assistance, and expanding access — never distributed as profit. When your health is on the line, cost should never be the reason you go without answers.
We're partnering with private insurers to have the MCT - 1 recognized as a covered medical device and remote patient monitoring (RPM) tool, so eligible patients pay little to nothing out of pocket.
Insurers cover devices that are medically necessary and backed by evidence. Our job is to make that case clearly — pairing the MCT - 1's continuous mast cell data with the research and outcomes payers look for — and to reduce the paperwork burden that so often stands between a patient and an approved claim.
As partnerships come online, we'll publish which plans and regions are supported, along with guidance on benefits verification and appeals if a claim is initially denied.
Public programs are how millions of seniors and low-income Americans get their care. We are actively working through Medicaid and Medicare pathways so that continuous mast cell monitoring can be accessed as a covered benefit — not a luxury reserved for those who can pay cash.
These pathways take time and regulatory clearance, and they vary state by state for Medicaid. We're committed to doing that work so eligibility follows need, not income.
The MCT - 1 is designed to fit into care, not around it. We collaborate directly with physicians, allergists, immunologists, clinics, and health systems so the device can be prescribed, fitted, and monitored as part of a patient's existing treatment plan.
Continuous data flows to the app and can support clinical decision-making, with tooling designed to fit remote patient monitoring workflows and existing EHR-adjacent processes.
Through our For Clinicians program, providers and clinics can partner with us to prescribe and monitor the MCT - 1, and to help shape how continuous mast cell data supports their patients.
The MCT - 1 is eligible for purchase with Health Savings Account (HSA) and Flexible Spending Account (FSA) funds as a qualified medical device — an immediate way to lower the real cost of care.
As a non-profit, affordability is part of our mission — not an afterthought.
Ask your care team whether continuous mast cell monitoring is right for you and can be prescribed.
We'll help verify insurance, Medicaid/Medicare, or HSA/FSA eligibility for your plan and region.
If cost is a barrier, apply for patient assistance or sliding-scale pricing.
Receive your MCT - 1, pair the app, and begin continuous, covered monitoring.
We are actively partnering with private insurers to have the MCT - 1 recognized as a covered medical device and remote patient monitoring tool. Coverage partnerships are in active development and subject to payer approval, so specific in-network benefits will vary by plan and region.
We are pursuing Medicaid and Medicare coverage pathways so that seniors and low-income patients can access continuous mast cell monitoring as a covered benefit. These public-program pathways are in development and subject to regulatory clearance and program approval, and Medicaid rules vary by state.
Yes. The MCT - 1 is eligible for purchase with HSA and FSA funds as a qualified medical device. Eligibility can vary by plan, so confirm details with your plan administrator.
As a non-profit, we offer a patient assistance program and sliding-scale pricing based on household income. No one is turned away from a medically necessary device for inability to pay.
We collaborate directly with providers, clinics, and health systems so the MCT - 1 can be prescribed, fitted, and monitored as part of existing care. Reach out through our For Clinicians program to begin a partnership.
Whether you're a patient exploring coverage or a clinician who wants to partner, we'd love to help.
Reserve the MCT - 1 For clinicians*Coverage partnerships are in active development and subject to payer approval and regulatory clearance. Availability of insurance, Medicaid, Medicare, HSA/FSA, and patient-assistance benefits varies by plan, program, state, and region. This page is informational and is not a guarantee of coverage or medical advice.